Wednesday - September 2, 2026
Miller School Trial Tests Testosterone Therapy in Men With Low-Risk Prostate Cancer
August 28, 2026
MIAMI, Florida, Aug. 28 -- The University of Miami Miller School of Medicine posted the following news:

* * *

Miller School Trial Tests Testosterone Therapy in Men With Low-Risk Prostate Cancer

*

Researchers are evaluating whether weekly testosterone cypionate injections can be used safely in carefully selected men with low-risk prostate cancer who are undergoing active surveillance.

Researchers at the University of Miami Miller Sc . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products